Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

FDA
News

ClearPoint Neuro Teceives FDA 510(k) Clearance For ClearPoint Array System

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K214040

byBenzinga Newsdesk

April 18, 2022

1 minute read

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K214040

News

Altus Power, Inc. Announces Redemption Of Public And Private Placement Warrants

By Benzinga Newsdesk

Today, 7:06 AM

Altus Power, Inc. (NYSE:AMPS) ("Altus Power" or the "Company"), the premier independent developer, owner and operator of commercial-scale solar facilities, today announced that it will redeem all of

AMPS

Morgan Stanley Maintains Overweight on Arcutis Biotherapeutics, Raises Price Target to $49

By Benzinga Newsdesk

Today, 7:06 AM

Morgan Stanley analyst Vikram Purohit maintains Arcutis Biotherapeutics (NASDAQ:ARQT) with a Overweight and raises the price target from $46 to $49.

ARQT

Urban Tea Undergoes Corporate Rebranding, Changes Name To Bit Brother Limited

By Shivani Kumaresan

Today, 7:06 AM

Urban Tea Inc (NASDAQ:MYT) said it would change its name to Bit Brother Limited, effective June 16, 2021. The company will trade…

MYT

Lake Street Maintains Buy on Calavo Growers, Lowers Price Target to $50

By Benzinga Newsdesk

Today, 7:06 AM

Lake Street analyst Ben Klieve maintains Calavo Growers (NASDAQ:CVGW) with a Buy and lowers the price target from $60 to $50.

CVGW

ClearPoint Neuro Teceives FDA 510(k) Clearance For ClearPoint Array System

Related Posts

Altus Power, Inc. Announces Redemption Of Public And Private Placement Warrants

Morgan Stanley Maintains Overweight on Arcutis Biotherapeutics, Raises Price Target to $49

Urban Tea Undergoes Corporate Rebranding, Changes Name To Bit Brother Limited

Lake Street Maintains Buy on Calavo Growers, Lowers Price Target to $50